Isolation and identification of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs

Abstract

The cancer stem cells (CSCs) from human osteosarcoma by serum-free three-dimensional culture combined with anticancer drugs were isolated and identified. The primary cells derived from human osteosarcoma were digested by trypsin to prepare a single-cell suspension, and mixed homogeneously into 1.2% alginate gel. Single-cell alginate gel was cultured with serum-free DMEM/F12 medium. Epirubicin (0.8 μg/mL) was added to the medium to enrich CSCs. After cultured conventionally for 7 to 10 days, most of cells suspended in alginate gel were killed by epirubicin. But few cells survived and some single-cell cloning spheres formed. Immunofluorescent staining for Oct3/4 and Nanog was implemented to find cells with properties of self-renewal and multi-potential differentiation. Cells from cloning spheres were transplanted into BALB/c mice to detect the tumorigenicity in vivo. The results showed that some cells positive for Oct3/4 (TRITC) and Nanog (TRITC) were found in single-cell cloning spheres, and most of positive cells were concentrated in the core of sphere. Cells from spheres could form osteosarcoma in the body of mice. It was concluded that cells from single-cell cloning spheres had the properties of the expression of parts of stem cell genes (Oct3/4 and Nanog), resisting anti-cancer drugs, and tumorigenicity in vivo. To sum up, it is believed that cells obtained from osteosarcoma by serum-free three-dimensional culture combined with anticancer drugs are cancer stem cells.

Keywords

three-dimensional culture / serum-free culture / epirubicin / osteosarcoma / cancer stem cells

References

[1] GattaG., CapocacciaR., StillerC., et al.. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol, 2005, 23(16): 3742-3751

[2] MeyersP.A., SchwartzC.L., KrailoM., et al.. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol, 2005, 23(9): 2004-2011

[3] ReyaT., MorrisonS.J., ClarkeM.F., et al.. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414(6859): 105-111

[4] MarxJ.. Mutant stem cells may seed cancer. Science, 2003, 301(5638): 1308-1310

[5] Al-HajjM., WichaM.S., Benito-HernandezA., et al.. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100: 3983-3988

[6] GalliR., BindaE., OrfanelliU., et al.. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 2004, 64(19): 7011-7021

[7] CollinsA.T., BerryP.A., HydeC., et al.. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 2005, 65(23): 10 946-10 951

[8] Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121(6):823–835

[9] Ricci-VitianiL., LombardiD.G., PilozziE., et al.. Identification and expansion of human colon-cancer-initiating cells. Nature, 2007, 445(7123): 111-115

[10] YinS., LiJ., HuC., et al.. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer, 2007, 120(7): 1444-1450

[11] YangZ.F., NgaiP., HoD.W., et al.. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology, 2008, 47(3): 919-928

[12] WoodwardW.A., SulmanE.P.. Cancer stem cells: markers or biomarkers?. Cancer Metastasis Rev, 2008, 27(3): 459-470

[13] PhillipsT.M., McBrideW.H., PajonkF.. The response of CD24 (/low)/CD44⁺ breast cancer-initiating cells to radiation. J Natl Cancer Inst, 2006, 98(24): 1777-1785

[14] InagakiA., SoedaA., OkaN., et al.. Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions. Biochem Biophys Res Commun, 2007, 361(3): 586-592

[15] SutherlandR.M.. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science, 1988, 240(4849): 177-184

[16] KelmJ.M., KramerB.P., Gonzalez-NicoliniV., et al.. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng, 2003, 83(2): 173-180

[17] FischbachC., ChenR., MatsumotoT., et al.. Engineering tumors with 3D scaffolds. Nat Methods, 2007, 4(10): 855-860

[18] JeonO., BouhadirK.H., MansourJ.M., et al.. Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials, 2009, 30(14): 2724-2734

[19] de VosP., FaasM.M., StrandB., et al.. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials, 2006, 27(32): 5603-5617

[20] WestE.R., XuM., WoodruffT.K., et al.. Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials, 2007, 28(30): 4439-4448

[21] MarkusenJ.F., MasonC., HullD.A., et al.. Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng, 2006, 12(4): 821-830

[22] SagarJ., ChaibB., SalesK., et al.. Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int, 2007, 7: 9

[23] TodaS., WatanabeK., YokoiF., et al.. A new organotypic culture of thyroid tissue maintains three-dimensional follicles with C cells for a long term. Biochem Biophys Res Commun, 2002, 294(4): 906-911

[24] NicholsJ., ZevnikB., AnastassiadisK., et al.. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell, 1998, 95(3): 379-391

[25] Hoei-HansenC.E., AlmstrupK., NielsenJ.E., et al.. Stem cell pluripotency factor Nanog is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology, 2005, 47(1): 48-56

[26] YuanX., CurtinJ., XiongY., et al.. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene, 2004, 23(58): 9392-9400

[27] SinghS.K., ClarkeI.D., TerasakiM., et al.. Identification of a cancer stem cell in human brain tumors. Cancer Res, 2003, 63(18): 5821-5828

[28] KondoT., SetoguchiT., TagaT.. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA, 2004, 101(3): 781-786